Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on July 8, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print July 8, 2004, doi: 10.1161/01.ATV.0000137975.14996.df
A more recent version of this article appeared on September 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/9/1703    most recent
01.ATV.0000137975.14996.dfv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welty, F. K.
Right arrow Articles by Schaefer, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welty, F. K.
Right arrow Articles by Schaefer, E. J.

Submitted on May 6, 2004
Accepted on June 3, 2004

Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes

Francine K. Welty *; Alice H. Lichtenstein ; P. Hugh R. Barrett ; Gregory G. Dolnikowski ; and Ernst J. Schaefer

From the Lipid Metabolism Laboratory, Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Mass; the Division of Cardiology (F.K.W.), Beth Israel Deaconess Medical Center, and the School of Medicine and Pharmacology (P.H.R.B.), University of Western Australia, Perth, Australia.

* To whom correspondence should be addressed. E-mail: fwelty{at}bidmc.harvard.edu.

Objective--Our purpose was to determine the relationship between apolipoprotein (apo) A-I and apoB-48 and apoB-100 metabolism in moderately hypercholesterolemic humans.

Methods and Results--The kinetics of apoA-I within high-density lipoprotein (HDL), apoB-48 and apoB-100 within triglyceride-rich lipoproteins, and apoB-100 within intermediate-density lipoprotein and low density-lipoprotein (LDL) were examined with a primed constant infusion of [5,5,5-2H3] leucine in the fed state (hourly feeding) in 23 subjects after consumption of a 36% total fat diet. Lipoproteins were isolated by ultracentrifugation; apolipoproteins by SDS-PAGE gels; and isotope enrichment assessed by gas chromatograph/mass spectrometry. Kinetic parameters were calculated by multicompartmental modeling of the data with SAAM II. ApoA-I production rate (PR) was correlated with LDL apoB-100 pool size (PS; r=0.49; P=0.017) and LDL cholesterol (r=0.61; P=0.002), whereas apoA-I fractional catabolic rate (FCR) was inversely correlated with apoB-48 FCR (r=-0.40; P=0.05) but not with very low-density lipoprotein apoB-100 FCR.

Conclusions--Two links exist between apoA-I and apoB kinetics: 1) when LDL apoB-100 PS is high, there is increased apoA-I PR; and 2) delayed chylomicron remnant clearance (represented by apoB-48 FCR) is associated with enhanced apoA-I FCR, a finding indicating that alterations in intestinal lipoproteins may be more important in determining HDL cholesterol levels than changes in liver lipoproteins.


Key words: apolipoprotein A-I • apolipoprotein B • lipoprotein metabolism • stable isotopes • HDL cholesterol




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Franssen, R. R. Sankatsing, E. Hassink, B. Hutten, M. T. Ackermans, K. Brinkman, R. Oesterholt, A. Arenas-Pinto, S. P. Storfer, J. J. Kastelein, et al.
Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1336 - 1341.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Verges, E. Florentin, S. Baillot-Rudoni, J.-M. Petit, M. C. Brindisi, J.-P. Pais de Barros, L. Lagrost, P. Gambert, and L. Duvillard
Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
J. Lipid Res., June 1, 2009; 50(6): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. C. Chan, P. H. R. Barrett, E. M. M. Ooi, J. Ji, D. T. Chan, and G. F. Watts
Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Ramakrishnan
Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments
J. Lipid Res., December 1, 2006; 47(12): 2738 - 2753.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Zheng, K. Ikewaki, B. W. Walsh, and F. M. Sacks
Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat
J. Lipid Res., August 1, 2006; 47(8): 1771 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Duez, B. Lamarche, K. D. Uffelman, R. Valero, J. S. Cohn, and G. F. Lewis
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48-Containing Lipoproteins in Humans
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1357 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Lamon-Fava, B. Postfai, M. Diffenderfer, C. DeLuca, J. O'Connor Jr, F. K. Welty, G. G. Dolnikowski, P. H. R. Barrett, and E. J. Schaefer
Role of the Estrogen and Progestin in Hormonal Replacement Therapy on Apolipoprotein A-I Kinetics in Postmenopausal Women
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 385 - 391.
[Abstract] [Full Text] [PDF]